Pfizer Ltd. | PFIZER | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 15,231 | 17,719 | 19,143 | 22,199 | 11,151 |
Short-term investment |
| 188 | 137 | 137 | 352 | 352 |
Accounts receivables |
| 1,208 | 1,548 | 1,717 | 1,720 | 1,297 |
Inventories |
| 3,219 | 2,971 | 3,867 | 4,306 | 4,351 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 943 | 1,793 | 2,303 | 1,906 | 2,097 |
Total current assets |
| 20,789 | 24,167 | 27,167 | 30,483 | 19,247 |
Gross property plant... |
| 833 | 815 | 714 | 2,145 | 1,924 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 833 | 815 | 714 | 2,145 | 1,924 |
Work in Progress |
| 153 | 10 | 0 | 8 | 28 |
Miscellaneous Investment |
| 672 | 770 | 641 | 629 | 619 |
Deferred income taxes |
| 0 | 0 | 1,799 | 2,099 | 135 |
Intangible assets |
| 2,563 | 3,076 | 2,549 | 1,999 | 1,449 |
Goodwill |
| 5,275 | 5,275 | 5,275 | 5,275 | 5,275 |
Other long-term assets |
| 2,421 | 2,786 | 1,254 | 1,417 | 3,984 |
Total non-current assets |
| 11,917 | 12,732 | 12,233 | 13,572 | 13,412 |
Total assets |
| 32,706 | 36,900 | 39,400 | 44,054 | 32,659 |
Short-term debt |
| 0 | 25 | 25 | 25 | 25 |
Accounts Payable... |
| 3,978 | 4,956 | 4,359 | 4,268 | 2,837 |
Provisions |
| 582 | 635 | 624 | 577 | 806 |
Taxes Payable |
| 896 | 905 | 967 | 460 | 460 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other current liabilities |
| 2,414 | 3,023 | 2,942 | 3,404 | 3,615 |
Total current liabilities |
| 7,870 | 9,544 | 8,917 | 8,734 | 7,743 |
Long-term debt |
| 25 | 0 | 0 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 176 | 146 | 22 | 0 | 0 |
Provisions |
| 447 | 377 | 347 | 479 | 558 |
Capital Leases |
| 0 | 0 | 0 | 0 | 0 |
Other longterm liabilities |
| 0 | 0 | 0 | 887 | 427 |
Total non-current liabilities |
| 648 | 523 | 370 | 1,366 | 985 |
Total liabilities |
| 8,517 | 10,068 | 9,287 | 10,099 | 8,729 |
Share Capital |
| 457 | 458 | 458 | 458 | 458 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 23,731 | 26,375 | 29,656 | 33,497 | 23,473 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 24,189 | 26,832 | 30,113 | 33,955 | 23,930 |
Total Liabilities and Equity |
| 32,706 | 36,900 | 39,400 | 44,054 | 32,659 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |